New Market Study Published: Estonia Pharmaceuticals & Healthcare Report Q2 2013
Despite an upward revision we continue to view Estonia's pharmaceutical market as a relatively modest prospect in comparison to other regional markets. An ageing population and sedentary lifestyles have contributed to the increasing cardiovascular and oncologic burden on the state healthcare system, and, over the long term, growth is expected to be steady due to base effects. Nevertheless the size of the market will remain comparatively small.
View full press release